Nalaganje...
The role of glatiramer acetate in the early treatment of multiple sclerosis
The treatment of the underlying disease process causing multiple sclerosis has continued to evolve since the initial approval of interferon-beta-1b in 1993. Current emphasis is on early treatment, including treatment after a single clinical attack (clinically isolated syndrome). The assessment of wh...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2898171/ https://ncbi.nlm.nih.gov/pubmed/20628633 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|